SEC Form 4 filed by Director Wehmer Edward J

$SCL
Package Goods/Cosmetics
Consumer Discretionary
Get the next $SCL alert in real time by email
SEC FORM 4 SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
  
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
WEHMER EDWARD J

(Last) (First) (Middle)
1101 SKOKIE BOULEVARD, SUITE 500

(Street)
NORTHBROOK IL 60062

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
STEPAN CO [ SCL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
04/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Awards (1) 04/01/2025 04/01/2025 A 107 (2) (2) Common Stock 107 $55.4 15,281 D
Explanation of Responses:
1. Each Stock Award represents the right to receive one share of issuer common stock.
2. Stock Awards are payable in shares pursuant to the director's election either following separation from service or after a specified age.
/s/ James A. Hart, Attorney-in-fact for Edward J. Wehmer 04/03/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Get the next $SCL alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$SCL

DatePrice TargetRatingAnalyst
10/19/2023$89.00Neutral → Buy
CL King
3/11/2022$9.00 → $8.00Outperform
RBC Capital
12/20/2021$8.50 → $9.00Outperform
RBC Capital
More analyst ratings

$SCL
Press Releases

Fastest customizable press release news feed in the world

See more
  • Edward J. Wehmer to Retire from Stepan Company Board of Directors

    NORTHBROOK, Ill., Feb. 20, 2025 /PRNewswire/ -- Stepan Company (NYSE:SCL) today announced that Edward J. Wehmer has informed the Board of Directors of his decision to retire from the Board as of the date of the Company's next annual meeting of stockholders, which is scheduled for April 29, 2025. Mr. Wehmer will continue to serve on the Company's Board until that date. Mr. Wehmer joined the Company's Board in 2003. He has served as Lead Independent Director since 2016 and served as Chair of the Audit Committee from 2007 to 2023. "Ed has brought his considerable expertise and ta

    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary
  • Stepan Reports Fourth Quarter 2024 Results

    NORTHBROOK, Ill., Feb. 19, 2025 /PRNewswire/ -- Stepan Company (NYSE:SCL) today reported: Fourth Quarter 2024 Highlights Reported net income was $3.4 million versus a $1.2 million net loss in the prior year. Adjusted net income(1) was $2.8 million, down 63% versus prior year, largely due to higher pre-commissioning expenses at our new alkoxylation investment in Pasadena, Texas ($4.4 million increase), a one-time tax proceeding reserve of $2.9 million recorded in our Latin American operations and higher expenses associated with the previously announced CEO transition in the fou

    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary
  • Stepan Declares Quarterly Dividend

    NORTHBROOK, Ill., Feb. 19, 2025 /PRNewswire/ --  Stepan Company (NYSE:SCL) today reported: The Board of Directors of Stepan Company has declared a quarterly cash dividend on the Company's common stock of $0.385 per share. The dividend is payable on March 14, 2025, to common stockholders of record on March 3, 2025. The Company increased its quarterly cash dividend in the fourth quarter of 2024 by $0.010 per share, marking the 57th consecutive year that the Company has increased its cash dividend to stockholders. Corporate Profile Stepan Company is a major manufacturer of specia

    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary

$SCL
Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

See more

$SCL
Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

See more

$SCL
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

See more

$SCL
SEC Filings

See more

$SCL
Leadership Updates

Live Leadership Updates

See more
  • Stepan Promotes Luis E. Rojo to President and Chief Executive Officer

    NORTHBROOK, Ill., Oct. 30, 2024 /PRNewswire/ -- Stepan Company (NYSE:SCL) today announced the appointment of Luis E. Rojo as President and Chief Executive Officer and as a member of the Board of Directors, effective immediately. After a 31-year Stepan career, Scott R. Behrens is departing the Company to pursue other opportunities. "We thank Scott for his leadership and his many contributions to the growth and diversification of Stepan over his career with the Company. During his various roles in R&D, sales and marketing, and leadership, he helped diversify our market presence,

    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary
  • Stepan Company Announces Appointment of New Director

    NORTHBROOK, Ill., Feb. 15, 2024 /PRNewswire/ -- Stepan Company (NYSE:SCL) announced today the appointment of Susan M. Lewis as a Director of Stepan, effective on February 15, 2024. Ms. Lewis spent over 30 years at Dow Inc., a materials science company, and was part of the management team of Corteva, Inc., a global agriculture company, following its spinoff from DowDuPont Inc. Ms. Lewis served as Senior Vice President, Global Operations of Corteva from 2018 until her retirement in 2021, after which she worked as a business and executive consultant through 2023. Ms. Lewis held senior management roles with operations, sustainability and risk management responsibilities and led organizational r

    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary
  • AVITA Medical, Inc. Appoints Two New Non-Executive Members to the Board of Directors

    VALENCIA, Calif. and MELBOURNE, Australia, June 01, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ:RCEL, ASX: AVH))) ("AVITA Medical"), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, announced today the appointment of James Corbett and Jan Stern Reed to its Board of Directors effective July 1, 2021. Mr. Corbett has approximately 40 years of leadership experience in the medical device field, most recently, as CEO of CathWorks Ltd., a software-based medical technology company. Mr. Corbett has extensive global commercial and operating experience, serving as an

    $SCL
    $RCEL
    $ANGO
    Package Goods/Cosmetics
    Consumer Discretionary
    Medical/Dental Instruments
    Health Care

$SCL
Financials

Live finance-specific insights

See more
  • Stepan Reports Fourth Quarter 2024 Results

    NORTHBROOK, Ill., Feb. 19, 2025 /PRNewswire/ -- Stepan Company (NYSE:SCL) today reported: Fourth Quarter 2024 Highlights Reported net income was $3.4 million versus a $1.2 million net loss in the prior year. Adjusted net income(1) was $2.8 million, down 63% versus prior year, largely due to higher pre-commissioning expenses at our new alkoxylation investment in Pasadena, Texas ($4.4 million increase), a one-time tax proceeding reserve of $2.9 million recorded in our Latin American operations and higher expenses associated with the previously announced CEO transition in the fou

    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary
  • Stepan Declares Quarterly Dividend

    NORTHBROOK, Ill., Feb. 19, 2025 /PRNewswire/ --  Stepan Company (NYSE:SCL) today reported: The Board of Directors of Stepan Company has declared a quarterly cash dividend on the Company's common stock of $0.385 per share. The dividend is payable on March 14, 2025, to common stockholders of record on March 3, 2025. The Company increased its quarterly cash dividend in the fourth quarter of 2024 by $0.010 per share, marking the 57th consecutive year that the Company has increased its cash dividend to stockholders. Corporate Profile Stepan Company is a major manufacturer of specia

    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary
  • Stepan to Announce Fourth Quarter and Full Year 2024 Results on February 19, 2025

    NORTHBROOK, Ill., Jan. 29, 2025 /PRNewswire/ -- Stepan Company (NYSE:SCL) will issue its fourth quarter and full year 2024 earnings results on Wednesday, February 19, 2025 at approximately 7:00 a.m. ET (6:00 a.m. CT). Supporting slides will be posted at approximately the same time on the Investors/Presentations page at www.stepan.com. The Company will hold a conference call to discuss and answer questions about its financial and operational performance on the same day at 9:00 a.m. ET (8:00 a.m. CT). The call will be hosted by Luis E. Rojo, President and Chief Executive Officer

    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary

$SCL
Large Ownership Changes

This live feed shows all institutional transactions in real time.

See more